In Glaucoma Glaucoma is a group of eye conditions that damage the optic nerve, the health of which is vital for good vision. This damage is often caused by an abnormally high pressure in your eye. Glaucoma is one of the leading causes of blindness for people over the age of 60 or older. Mio Chol Injection is used to reduce swelling and pressure inside the eye. This helps to prevent complications of glaucoma such as blindness and improves the vision.
It is not known whether it is safe to consume alcohol with Mio Chol Injection. Please consult your doctor.
Mio Chol Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Mio Chol Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
It is not known whether Mio Chol Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Mio Chol Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Mio Chol Injection may not be needed in these patients. Please consult your doctor.
Mio Chol Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Mio Chol Injection may not be needed in these patients. Please consult your doctor.
If you miss a dose of Mio Chol Injection, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More